Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The effect of cell therapy with NGF on CSF cholinergic biomarkers in ten patients with Alzheimer´s disease

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-087-Tuesday
  • By: KARAMI, Azadeh (Karolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Stockholm, Sweden)
  • Co-author(s): Azadeh Karami: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Helga Eyjólfsdóttir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Swetha Vijayaraghavana: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Ahmadul Kadir: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Bengt Linderoth: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
    Göran Lind: Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden;Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
    Niels Andreasen: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
    Anders Wall: Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
    Åke Seiger: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Per Almqvist: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Department of Neurosurgery, Karolinska University Hospital, Karolinska University Hospital, Stockholm, Sweden
    Lars Wahlberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;, NsGene A/S, Ballerup, Denmark
    Agneta Nordberg: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
    Taher Darreh-Shori: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden
    Maria Eriksdotter: Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden;Department of Geriatric Medicine, Karolinska Institutet, Stockholm, Sweden
  • Abstract:

    Backgrounds

    Alzheimer’s disease (AD) is a progressive disease and the most common form of dementia with extensive loss of central cholinergic functions and a gradual decline in cognition and memory. Animal studies indicate that nerve growth factor (NGF) improves cholinergic functions, memory and cognitive behaviors. In addition, we have recently..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses